Summary
A reduction of digitoxin binding to plasma proteins during hemodialysis has been reported. Our aim was to determine whether this reduction is an in vivo effect or occurs only after blood collection as a result of heparin-induced lipolysis which increases levels of non-esterified fatty acids in vitro. Digitoxin protein binding was studied in 10 patients undergoing hemodialysis, receiving digitoxin maintenance therapy. Digitoxin free fraction was increased at the end of hemodialysis, from 2.5 ± 0.7% to 4.4 ± 1.1%, but after inhibition of in vitro lipolysis with paraoxon (2 mmol/1), a potent lipase inhibitor, there was no increase in the free fraction: 2.3 ± 0.4% before heparin and 2.4 ± 0.5% at the end of hemodialysis. Digitoxin salivary levels were also unchanged: 0.41 ± 0.08 ng/ml before heparin and 0.41 ± 0.08 ng/ml at the end of hemodialysis (n = 8). These data indicate that the binding of digitoxin in vivo is not altered during hemodialysis. The reduced binding reported elsewhere was a result of heparin-induced in vitro lipolysis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Behm HL, Wagner JG (1979) Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Pathol Pharmacol 26: 145–160
Brown JE, Kitchell BB, Bjornsson TD, Shand DG (1981) The artifactual nature of heparin-induced drug protein binding alterations. Clin Pharmacol Ther 30: 636–643
Chou RC, Levy G (1981) Does heparin cause inhibition of drug-protein binding in vivo? Clin Pharmacol Ther 29: 236–237
Danhof M, Breimer DD (1978) Therapeutic drug monitoring in saliva. Clin Pharmacokinet 3: 39–57
Doherty JE, Kane JJ (1975) Clinical pharmacology of digitalis glycosides. Ann Rev Med 26: 159–171
Dubé LM, Ho-Ngoc A, Davies RF, Beanlands DS, Mousseau N, McGilveray IJ (1983) Influence of protamine on heparin-induced increases of lidocaine free fraction. Res Commun Chem Pathol Pharmacol 42: 401–415
Giacomini KM, Giacomini JC, Blaschke TF (1980) Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins. Biochem Pharmacol 29: 3337–3340
Giacomini KM, Swezey SE, Giacomini JC, Blaschke TF (1980) Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. Life Sci 27: 771–780
Hooymans PM, Lohman JJHM, Overdiek JWPM, Merkus FWHM (1984) Free fraction and salivary level of digitoxin. Pharm Weekbl Sci Ed 6: 268
Krieglstein J (1981) Plasma protein binding of cardiac glycosides. In: Greeff K (ed) Cardiac Glycosides, Part II. Springer-Verlag, Berlin, pp 95–104
Lohman JJHM, Hooymans PM, Verhey MTJM, Koten MLP, Merkus FWHM (1984) Influence of volume shift in equilibrium dialysis to estimate plasma protein binding of drugs. Pharm Res 1: 187–188
Lohman JJHM, Hooymans PM, Koten MLP, Verhey MTJM, Merkus FWHM (1985) Effect of heparin on digitoxin protein binding. Clin Pharmacol Ther 37: 55–60
Pearce GA, Brown KF (1983) Heat inhibition of in vitro lipolysis and 14C-ibuprofen protein binding in plasma from heparinized uraemic subjects. Life Sci 33: 1457–1466
Porte D, Bierman EL (1969) The effect of heparin infusion on plasma triglyceride in vivo with a method for calculating triglyceride turnover. J Lab Clin Med 73: 631–648
Riemersma RA, Russell DC, Oliver MF (1981) Heparin-induced lipolysis, an exaggerated risk. Lancet 2: 471
Rizack MA (1960) Intravascular effect of heparin on plasma non-esterified fatty acid and triglyceride during alimentary lipemia. Proc Soc Exp Biol Med 104: 111–113
Schulz P, Giacomini KM, Lutrell S, Turner-Tamiyasu K, Blaschke TF (1983) Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man. Eur J Clin Pharmacol 25: 211–214
Storstein L (1976) Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin. Clin Pharmacol Ther 20: 6–14
Storstein L, Janssen H (1976) Studies on digitalis. VI. The effect of heparin on serum protein binding of digitoxin and digoxin. Clin Pharmacol Ther 20: 15–23
Tillement JP, Zini R, Lecomte M, D’Athis P (1980) Binding of digitoxin, digoxin and gitoxin to human serum albumin. Eur J Drug Metab Pharmacokinet 5: 129–134
Wilkins TA, Midgley JEM, Giles AF (1982) Treatment with heparin and results for free thyroxin: An in vivo or an in vitro effect? Clin Chem 28: 2441–2443
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lohman, J.J.H.M., Hooymans, P.M., Koten, M.L.P., Merkus, F.W.H.M. (1986). Digitoxin protein binding in patients on hemodialysis. In: Erdmann, E., Greef, K., Skou, J.C. (eds) Cardiac Glycosides 1785–1985. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-11292-2_44
Download citation
DOI: https://doi.org/10.1007/978-3-662-11292-2_44
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-662-11294-6
Online ISBN: 978-3-662-11292-2
eBook Packages: Springer Book Archive